ATE407689T1 - Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess - Google Patents

Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Info

Publication number
ATE407689T1
ATE407689T1 AT01954345T AT01954345T ATE407689T1 AT E407689 T1 ATE407689 T1 AT E407689T1 AT 01954345 T AT01954345 T AT 01954345T AT 01954345 T AT01954345 T AT 01954345T AT E407689 T1 ATE407689 T1 AT E407689T1
Authority
AT
Austria
Prior art keywords
evening primrose
primrose seed
aforementioned
defatted
absorption inhibitor
Prior art date
Application number
AT01954345T
Other languages
English (en)
Inventor
Yotaro Konishi
Michio Aitani
Hiroshi Yamaguchi
Tsutomu Arimura
Tadashi Okada
Hiromichi Murai
Original Assignee
Oryza Oil & Fat Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryza Oil & Fat Chem filed Critical Oryza Oil & Fat Chem
Application granted granted Critical
Publication of ATE407689T1 publication Critical patent/ATE407689T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT01954345T 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess ATE407689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000232930 2000-08-01

Publications (1)

Publication Number Publication Date
ATE407689T1 true ATE407689T1 (de) 2008-09-15

Family

ID=18725531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01954345T ATE407689T1 (de) 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Country Status (8)

Country Link
US (2) US6932990B2 (de)
EP (1) EP1312374B1 (de)
JP (1) JP4873824B2 (de)
CN (1) CN1268351C (de)
AT (1) ATE407689T1 (de)
AU (1) AU2001276682A1 (de)
DE (1) DE60135760D1 (de)
WO (1) WO2002009734A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
KR20030075947A (ko) * 2002-03-19 2003-09-26 제네티카 주식회사 신 혈관형성을 억제하는 물질
CN1668311A (zh) * 2002-07-24 2005-09-14 俄亥俄州立大学 治疗糖尿病的方法和组合物
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
CN1863543B (zh) * 2003-10-06 2010-06-16 奥力榨油化株式会社 减肥用组合物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1557094A1 (de) * 2004-01-26 2005-07-27 Wageningen Centre for Food Sciences Verbesserte halb-feste Lebensmittel und Methode zu ihrer Herstellung basierend auf der Inhibierung des von Amylasen induzierten Stärke Abbaus
US20050251265A1 (en) * 2004-05-07 2005-11-10 Calandruccio James H Trapezium implant for thumb and method
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
MX292792B (es) * 2004-06-04 2011-11-29 Horizon Science Pty Ltd Edulcorante natural.
JP5020462B2 (ja) * 2004-06-16 2012-09-05 クラシエフーズ株式会社 α−グルコシダーゼ阻害剤及びそれを用いた食品
JP2006016330A (ja) * 2004-06-30 2006-01-19 Suntory Ltd 脂肪燃焼促進剤
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
DE602005020646D1 (de) * 2004-08-30 2010-05-27 Takeda Pharmaceutical Screening-verfahren
CN100566723C (zh) * 2004-09-13 2009-12-09 辻田隆广 衍生自壳斗植物的糖酶抑制剂及其应用
JP2006104181A (ja) * 2004-09-13 2006-04-20 Takahiro Tsujita ブナ科植物由来の糖質分解酵素阻害物質、及びその用途
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
JP5775656B2 (ja) 2005-06-03 2015-09-09 ホリズン サイエンス ピーティーワイ リミテッド ボディマス再分布性を有する物質
WO2007019526A2 (en) * 2005-08-05 2007-02-15 Naturegen, Inc. Compositions and methods for controlling glucose and lipid uptake from foods
KR100829083B1 (ko) 2006-07-28 2008-05-16 재단법인 제주하이테크산업진흥원 생리활성을 갖는 애기달맞이 추출물
CN104323268A (zh) * 2006-09-19 2015-02-04 视界科技有限公司 从甘蔗中获得的提取物及其生产方法
WO2008093303A2 (en) * 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
RU2429853C2 (ru) * 2007-02-01 2011-09-27 Дзе Иамс Компани Способ уменьшения воспаления и окислительного стресса у млекопитающих
EP2303252A1 (de) 2008-05-15 2011-04-06 Alois Jungbauer Verbindungen zur behandlung des metabolischen syndroms und von insulin-resistenz
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP4201408B1 (de) * 2008-08-22 2025-06-25 Vifor (International) Ltd. Vernetzte kationenaustauschpolymere, zusammensetzungen und verwendung bei der behandlung von hyperkalämie
EP2340844A4 (de) * 2008-10-08 2012-10-31 Pokka Corp Mittel gegen vogelgrippevirus und ein mittel gegen das vogelgrippevirus entaltendes produkt
JP2010184909A (ja) * 2009-02-13 2010-08-26 Rheology Kino Shokuhin Kenkyusho:Kk 機能性組成物およびこの組成物を含有する医薬又は健康食品
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102018766B (zh) 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
EP2672832B1 (de) 2011-02-08 2020-03-25 The Product Makers (Australia) Pty Ltd Zuckerextrakte
RU2451506C1 (ru) * 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
AU2013308395C1 (en) 2012-08-28 2018-03-15 Poly Gain Pte Ltd Extraction method
JP2014198684A (ja) * 2013-03-29 2014-10-23 サンスター株式会社 血糖代謝改善剤
WO2015021512A1 (en) 2013-08-16 2015-02-19 Horizon Science Pty Ltd Sugar cane derived extracts and methods of treatment
JP6998108B2 (ja) 2016-03-07 2022-01-18 株式会社ダイセル ウロリチン類を含有するα－グルコシダーゼ活性阻害剤、およびウロリチン類を含有する血糖値上昇抑制剤
CN111526735A (zh) * 2017-12-27 2020-08-11 三得利控股株式会社 肠道屏障功能改善用组合物
JPWO2022085602A1 (de) * 2020-10-20 2022-04-28
JP7884819B2 (ja) * 2021-09-01 2026-07-06 ビーエイチエヌ株式会社 血糖値上昇抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3018013B2 (ja) 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤
DE69633502T2 (de) 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
JPH09176019A (ja) * 1995-12-26 1997-07-08 Suntory Ltd 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
AU9369198A (en) * 1998-09-30 2000-04-17 Industrial Research Limited Antioxidant compositions and process for their preparation

Also Published As

Publication number Publication date
US6932990B2 (en) 2005-08-23
CN1268351C (zh) 2006-08-09
EP1312374A1 (de) 2003-05-21
WO2002009734A1 (en) 2002-02-07
WO2002009734A8 (en) 2002-02-28
DE60135760D1 (de) 2008-10-23
EP1312374A4 (de) 2004-04-21
JP4873824B2 (ja) 2012-02-08
US20030161903A1 (en) 2003-08-28
CN1468106A (zh) 2004-01-14
AU2001276682A1 (en) 2002-02-13
EP1312374B1 (de) 2008-09-10
US20060024396A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
DE60135760D1 (de) Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess
Bennour et al. Effect of solvent evaporation method on phenolic compounds and the antioxidant activity of Moringa oleifera cultivated in Southern Tunisia
Oniszczuk et al. Extraction methods for the determination of phenolic compounds from Equisetum arvense L. herb
Rostagno et al. Pressurized liquid extraction of isoflavones from soybeans
Soumaya et al. Preliminary phytochemical analysis, antioxidant, anti-inflammatory and anticancer activities of two Tunisian Ephedra species: Ephedra alata and Ephedra fragilis
M’rabet et al. Profiling of phenolic compounds and antioxidant activity of Melia azedarach L. leaves and fruits at two stages of maturity
Pacifico et al. Neuroprotective potential of Laurus nobilis antioxidant polyphenol-enriched leaf extracts
Abd Ghafar et al. Antioxidant, α-glucosidase, and nitric oxide inhibitory activities of Phyllanthus acidus and LC–MS/MS profile of the active extract
Susanti et al. Bioactive constituents from the leaves of Melastoma malabathricum L.
Díaz-de-Cerio et al. Establishment of pressurized-liquid extraction by response surface methodology approach coupled to HPLC-DAD-TOF-MS for the determination of phenolic compounds of myrtle leaves: Díaz-de-Cerio E. et al.
Tung et al. Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice
CA2633571A1 (en) Recovery of residual plant components after distillation of essential oils
Sitthisak et al. Efficient extraction of quassinoids and alkaloids from Eurycoma longifolia Jack roots using natural deep eutectic solvents and microwave-assisted extraction
Hosseini et al. Antioxidant effect of Achillea wilhelmsii extract on pentylenetetrazole (seizure model)-induced oxidative brain damage in Wistar rats
Pires et al. Qualitative and quantitative analysis of the phenolic content of Connarus var. angustifolius, Cecropia obtusa, Cecropia palmata and Mansoa alliacea based on HPLC-DAD and UHPLC-ESI-MS/MS
CA3043168C (en) Composition containing oroxylin a and method of extraction thereof
Zielińska-Pisklak et al. Activity-guided isolation, identification and quantification of biologically active isomeric compounds from folk medicinal plant Desmodium adscendens using high performance liquid chromatography with diode array detector, mass spectrometry and multidimentional nuclear magnetic resonance spectroscopy
Nugroho et al. Simultaneous analysis and peroxynitrite-scavenging activity of galloylated flavonoid glycosides and ellagic acid in Euphorbia supina
Alilou et al. Screening phytochimique et identification spectroscopique des flavonoïdes d’Asteriscusgraveolenssubsp. odorus
de Almeida et al. Phenolic compounds of Triplaris gardneriana can protect cells against oxidative stress and restore oxidative balance
Raduan et al. Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions
Rivero-Cruz et al. Quantitative analysis and pharmacological effects of Artemisia ludoviciana aqueous extract and compounds
KR20010052636A (ko) 하이페리쿰 퍼포라툼의 추출물 및 그를 함유한 제제
EP1795201A1 (de) Isolierung von Oleuropein aus Blättern des Olivenbaums
AU2025242225A1 (en) Method for obtaining oleocanthal type secoiridoids and for producing respective pharmaceutical preparations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties